Molinalogo

PI Coding Policy General

PI Coding Policy Diagnosis Code

PI Coding Policy ICD-10 Specificity

PI Coding Policy Lab Codes with Modifiers 59 and 91

PI Coding Policy Modifier 26

PI Coding Policy Modifier KK

PI Coding Policy Modifier TC

PI Coding Policy Packaged and conditionally packaged lab services

PI Coding Policy Therapy Modifier

PI Coding Policy NCCI PTP with Modifiers

PI Code Coding Policy Add-On

PI Coding Policy Ambulance Modifier

PI Coding Policy Medically Unlikely Edits

PI Coding Policy Decision for Surgery

PI Coding Policy Lab Panel

PI Coding Policy Image Guided Radiation Therapy

PI Coding Policy Non-Invasive Prenatal Testing

PI Coding Policy ICD-10 First Listed Diagnosis

PI Coding Policy Excludes1 Note

 

PI Payment Policy 38 Critical Care Codes when Discharging Home

PI Payment Policy 35 Breast Cancer Genetic Testing Tier 1 vs Tier 2

PI Payment Policy 47 Psychotherapy Add-On with High Level EM

PI Payment Policy 36 Hydrolyzed Enteral Formula Diagnosis

PI Payment Policy 37 High-Level EM with Preventive Medicine

PI Payment Policy 46 Split-Night Sleep Study

PI Payment Policy 1 Hospital Routine Supplies Services Reimbursement
PI Payment Policy 25 DRG Clinical Validation
PI Payment Policy 32 Newborn and NICU
PI Payment Policy 34 Appropriate Level of Care Reimbursement

Clinical Payment Policy G2002 Cervical Cancer Screening

Clinical Payment Policy F2019 Flow Cytometry

Clinical Payment Policy G2005 Vitamin D Testing

Clinical Payment Policy G2006 Hemoglobin A1c

Clinical Payment Policy G2007 Prostate Biopsies

Clinical Payment Policy G2008 Prostate Specific Antigen PSA Testing

Clinical Payment Policy G2009 Preventive Screening in Adults

Clinical Payment Policy G2011 Diagnostic Testing of Iron Homeostasis and Metabolism

Clinical Payment Policy G2013 Testosterone Testing

Clinical Payment Policy G2014 Vitamin B12 and Methylmalonic Acid Testing

Clinical Payment Policy G2022 ANA ENA Testing

Clinical Payment Policy G2031 Allergen Testing

Clinical Payment Policy G2036 Hepatitis C

Clinical Payment Policy G2042 Pediatric Preventive Screening

Clinical Payment Policy G2043 Celiac Disease Testing

Clinical Payment Policy G2044 Helicobacter pylori Testing

Clinical Payment Policy G2045 Thyroid Disease Testing

Clinical Payment Policy G2048 Biochemical Markers of Alzheimer Disease and Dementia

Clinical Payment Policy G2050 Cardiovascular Disease Risk Assessment

Clinical Payment Policy G2051 Bone Turnover Markers Testing

Clinical Payment Policy G2056 Diagnosis of Idiopathic Environmental Intolerance

Clinical Payment Policy G2059 Epithelial Cell Cytology In Breast Cancer Risk Assessment

Clinical Payment Policy G2060 Fecal Analysis in the Diagnosis of Intestinal Dysbiosis and Fecal Microbiota Transplant Testing

Clinical Payment Policy G2061 Fecal Calprotectin Testing in Adults

Clinical Payment Policy G2063 Testing for Diagnosis of Active or Latent Tuberculosis

Clinical Payment Policy G2098 Immune Cell Function Assay

Clinical Payment Policy G2099 Intracellular Micronutrient Analysis

Clinical Payment Policy G2100 In Vitro Chemoresistance and Chemosensitivity Assays

Clinical Payment Policy G2105 Immunopharmacologic Monitoring of Therapeutic Serum Antibodies

Clinical Payment Policy G2107 Measurement of Thromboxane Metabolites for ASA Resistance

Clinical Payment Policy G2110 Serum Testing for Hepatic Fibrosis in the Evaluation and Monitoring of Chronic Liver Disease

Clinical Payment Policy G2113 Oral Screening Lesion Identification Systems and Genetic Screening

Clinical Payment Policy G2115 Metabolite Markers of Thiopurines Testing

Clinical Payment Policy G2119 Diagnostic Testing of Influenza

Clinical Payment Policy G2120 Salivary Hormone Testing

Clinical Payment Policy G2121 Laboratory Testing for the Diagnosis of Inflammatory Bowel Disease

Clinical Payment Policy G2123 Biomarker Testing for Multiple Sclerosis and Related Neurologic Diseases

Clinical Payment Policy G2124 Serum Tumor Markers for Malignancies

Clinical Payment Policy G2125 Urinary Tumor Markers For Bladder Cancer

Clinical Payment Policy G2127 Vectra DA Blood Test for Rheumatoid Arthritis

Clinical Payment Policy G2130 ST2 Assay for Chronic Heart Failure

Clinical Payment Policy G2132 Erectile Dysfunction

Clinical Payment Policy G2133 ZIKA Virus Risk Assessment

Clinical Payment Policy G2138 Evaluation of Dry Eyes

Clinical Payment Policy G2143 Lyme Disease

Clinical Payment Policy G2149 Pathogen Panel Testing

Clinical Payment Policy G2150 Cardiac Biomarkers for Myocardial Infarction

Clinical Payment Policy G2153 Pancreatic Enzyme Testing for Acute Pancreatitis

Clinical Payment Policy G2154 Folate Testing

Clinical Payment Policy G2155 General Inflammation Testing

Clinical Payment Policy G2156 Urine Culture Testing For Bacteria

Clinical Payment Policy G2157 Diagnostic Testing of Common Sexually Transmitted Infections

Clinical Payment Policy G2158 Testing for Mosquito- or Tick-Related Infections

Clinical Payment Policy G2159 BHemolytic Streptococcus Testing

Clinical Payment Policy G2164 Parathyroid Hormone Phosphorus Calcium and Magnesium Testing

Clinical Payment Policy G2173 Gamma-Glutamyl Transferase

Clinical Payment Policy M2041 Venous and Arterial Thrombosis Risk Testing

Clinical Payment Policy M2057 Diagnosis of Vaginitis Including Multi Target PCR Testing

Clinical Payment Policy M2058 Genetic Testing for Adolescent Idiopathic Scoliosis

Clinical Payment Policy M2068 Testing for Alpha 1 Antitrypsin Deficiency

Clinical Payment Policy M2091 Transplant Rejection Testing

Clinical Payment Policy M2093 HIV Genotyping and Phenotyping

Clinical Payment Policy M2097 Identification Of Microorganisms Using Nucleic Acid Probes

Clinical Payment Policy M2112 Nerve Fiber Density Testing

Clinical Payment Policy M2116 Plasma HIV1 and HIV2 RNA Quantification for HIV Infection

Clinical Payment Policy M2136 DNA Ploidy Cell Cycle Analysis

Clinical Payment Policy M2172 Onychomycosis Testing

Clinical Payment Policy P2018 Immunohistochemistry

Clinical Payment Policy R2162 Laboratory Procedures Reimbursement Policy